Abeona Therapeutics Inc vs Wheaton Precious Metals Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Wheaton Precious Metals Corp trades at $136.03 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 144.7× Abeona Therapeutics Inc's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | WPM | |
|---|---|---|
Market Cap | $421.19M | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $7.45 | $165.72 |
52-Week Low | $4.17 | $91.02 |
Enterprise Value | $276.10M | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →